One of the possible mechanisms contributing to the development of Alzheimer’s disease is gut dysbiosis. Gut dysbiosis is where the intestinal flora or bacteria living in the large intestines are unbalanced. Amino acids produced by less beneficial bacteria can trigger an inflammatory response leading to neuroinflammation.
New drug therapies have been developed and are being trialed that remodel the microbiome. Reducing these amino acids may reduce the infiltration of immune cells to the brain, and in turn reduce neuroinflammation. Read more